Pseudomonas cepacia susceptibility to sulbactam-Reference-Cited by-同舟云学术

Pseudomonas cepacia susceptibility to sulbactam

Published:1989-04 Issue:4 Volume:33 Page:583-584
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Jacoby G A¹,Sutton L¹

Affiliation:

1. Massachusetts General Hospital, Boston 02114.

Abstract

For 25 of 32 Pseudomonas cepacia isolates, predominantly from sputum of adult patients, agar dilution MICs of sulbactam were 2.5 micrograms/ml, and for only one was the MIC more than 80 micrograms/ml. Susceptibility was reliably predicted by response to a commercial sulbactam-ampicillin disk.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.33.4.583

Reference7 articles.

1. Gold R. E. Jin H. Levison A. Isles and P. C. Fleming. 1983. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J. Antimicrob. Chemother. 12(Suppl. A):331-336.

2. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology;Goldmann D. A.;J. Pediatr.,1986

3. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem;Isles A.;J. Pediatr.,1984

4. In vitro susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to trimethoprim and trimethoprim-sulfamethoxazole;Moody M. R.;Antimicrob. Agents Chemother.,1975

5. Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts;Noriega E. R.;Am. J. Med.,1973

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. War against ESKAPE Pathogens;Bacterial Infectious Diseases Annual Volume 2023;2023-12-20

2. In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam-Durlobactam against Pathogenic Burkholderia Species;Antimicrobial Agents and Chemotherapy;2021-02-17

3. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review;International Journal of Molecular Sciences;2019-11-21

4. Avibactam Sensitizes Carbapenem-Resistant NDM-1–Producing Klebsiella pneumoniae to Innate Immune Clearance;The Journal of Infectious Diseases;2019-03-29

5. β-Lactams and β-Lactamase Inhibitors: An Overview;Cold Spring Harbor Perspectives in Medicine;2016-06-21